China NMPA Product Recall - Arterial puncture catheter group

Arrow International LLC initiated a voluntary Class I recall of its arterial catheter assemblies, a significant action reported to the National Medical Products Administration (NMPA) on March 25, 2024. This recall, reported by Telefi Medical Devices Trading (Shanghai) Co., Ltd., addresses a critical safety concern: the potential for resistance when utilizing the guidewire handle/lumen of these devices. Such resistance could compromise the intended function of the catheter during medical procedures, thereby posing a substantial risk to patient safety. The affected products are specific arterial puncture catheters, identified under Registration Certificate No.: 20163032161. A Class I designation signifies the most serious level of recall, indicating a high probability that the use of or exposure to the faulty product could lead to severe adverse health consequences or even death. For comprehensive information regarding the precise models, specifications, and batch numbers of the impacted devices, stakeholders are directed to consult the detailed 'Medical Device Recall Event Report Form.' This proactive regulatory measure by Arrow International LLC, under the NMPA's oversight, highlights a commitment to product safety and prompt corrective action.